Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) recently highlighted encouraging new clinical data for its allogeneic CAR-T therapy ...

This ASX healthcare stock could double in value over the next 12 months according to the team at Bell Potter. Let's see ...

With so much market uncertainty this year, major car brands are willing to discount ...

Looking for investments built to last? Here are two to consider. The post 2 excellent ASX 200 shares that look built for the ...

An all-new Mitsubishi ASX small SUV – developed in-house by the Japanese giant, not a rebadged Renault Captur – finally appears to be on the way for the 18th birthday of the original. News agency ...

The ASX bounced on Tuesday as investors hid in Woolies while the RBA warned the road ahead could get bumpier. ... Read More ...

AI didn't kill ASX SaaS stocks – it killed the multiples investors would pay for them. That distinction could make or break your portfolio.

Majority of stocks fall as US and Iran trade fresh blows, sparking oil spike; gold falls to two-month low; Siteminder soars ...

As the Australian market looks to potentially rebound following positive developments on Wall Street and a dip in Brent crude prices, investors are also weighing the implications of recent interest ...

Mitsubishi acknowledges that its new ASX is a slow seller, but it's far from giving up on its European-built small SUV.

Miners rode the copper buzz, while GYG’s US exit and a fresh wave of deals kept traders shuffling the deck. ... Read More The ...

Supposedly vulnerable with soaring interest rates and sagging consumer confidence, the non-bank lenders are outperforming the banks by focusing on niche sectors with a careful eye on credit quality.